USA > Japan’s Otsuka Pharmaceutical to acquire US based Neurovance

Otsuka_Holdings_logo.svg Japan based Otsuka Pharmaceutical Company (OPC) to acquire USA based Neurovance. The acquisition of Neurovance comes with the hefty sum of $100 million and additional $150 million contingent on achievement of development and approval milestones with additional payments contingent on achievement of sales milestones set by OPC. The transaction is set to close by second quarter of 2017 but is More …